A multicenter, randomized, double-blind trial of prednisolone plus azathioprine versus prednisolone plus placebo in myasthenia gravis

被引：0
|
作者：
Palace, J
NewsomDavis, J
Lecky, B
机构：
来源：
NEUROLOGY | 1996年 / 46卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：32001 / 32001
页数：1
相关论文
共 50 条
  • [31] PRELIMINARY-RESULTS OF A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CYCLOSPORINE IN MYASTHENIA-GRAVIS
    TINDALL, RSA
    ROLLINS, JA
    PHILLIPS, JT
    GREENLEE, RG
    WELLS, L
    BELENDIUK, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (12): : 719 - 724
  • [32] A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel/Prednisolone in Patients with Hormone-Refractory Prostate Cancer
    Horti, Jozsef
    Widmark, Anders
    Stenzl, Arnulf
    Federico, Miriam H.
    Abratt, Raymond P.
    Sanders, Nick
    Pover, Gillian M.
    Bodrogi, Istvan
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2009, 24 (02) : 175 - 180
  • [33] Lidocaine Plus Morphine Versus Lidocaine Plus Paracetamol for Bier Block: A Double-Blind Randomized Controlled Trial
    Rafiei, Mohamadreza
    Afsahi, Mohamad
    Karbalaeikhani, Ali
    Kheradmand, Behroz
    Hazrati, Ebrahim
    JOURNAL OF PERIANESTHESIA NURSING, 2022, 37 (03) : 380 - 385
  • [34] Efficacy and safety of oral prednisolone tapering following intravenous methyl prednisolone in patients with multiple sclerosis relapses: A randomized, double-blind, placebo-controlled trial
    Bazi, Aliyeh
    Baghbanian, Seyed Mohammad
    Ghazaeian, Monireh
    Saeedi, Majid
    Hendoiee, Narjes
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
  • [35] INTERIM EVALUATION OF A PROSPECTIVE DOUBLE-BLIND TRIAL OF URSODESOXYCHOLIC ACID (UDCA) VERSUS UDCA PLUS PREDNISOLONE IN PRIMARY BILIARY-CIRRHOSIS (PBC)
    LEUSCHNER, M
    GULDUTUNA, S
    BENJAMINOV, A
    HUBNER, K
    LEUSCHNER, U
    GASTROENTEROLOGY, 1993, 104 (04) : A938 - A938
  • [36] Prednisone plus methotrexate for polymyalgia rheumatica - A randomized, double-blind, placebo-controlled trial
    Caporali, R
    Cimmino, MA
    Ferraccioli, G
    Gerli, R
    Klersy, C
    Salvarani, C
    Montecucco, C
    ANNALS OF INTERNAL MEDICINE, 2004, 141 (07) : 493 - 500
  • [37] A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis
    Naveau, S
    Chollet-Martin, S
    Dharancy, S
    Mathurin, P
    Jouet, P
    Piquet, MA
    Davion, T
    Oberti, F
    Broët, P
    Emilie, D
    HEPATOLOGY, 2004, 39 (05) : 1390 - 1397
  • [38] Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma
    Kindler, Hedy L.
    Karrison, Theodore G.
    Gandara, David R.
    Lu, Charles
    Krug, Lee M.
    Stevenson, James P.
    Jaenne, Pasi A.
    Quinn, David I.
    Koczywas, Marianna N.
    Brahmer, Julie R.
    Albain, Kathy S.
    Taber, David A.
    Armato, Samuel G., III
    Vogelzang, Nicholas J.
    Chen, Helen X.
    Stadler, Walter M.
    Vokes, Everett E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (20) : 2509 - 2515
  • [39] Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression
    Weissman, Judith
    Flint, Alastair
    Meyers, Barnett
    Ghosh, Samiran
    Mulsant, Benoit
    Rothschild, Anthony
    Whyte, Ellen
    PSYCHIATRY RESEARCH, 2012, 197 (03) : 221 - 226
  • [40] Randomized Double-Blind Phase II Trial Comparing Gemcitabine Plus LY293111 Versus Gemcitabine Plus Placebo in Advanced Adenocarcinoma of the Pancreas
    Saif, Muhammad Wasif
    Oettle, H.
    Vervenne, W. L.
    Thomas, J. P.
    Spitzer, G.
    Visseren-Grul, C.
    Enas, N.
    Richards, D. A.
    CANCER JOURNAL, 2009, 15 (04): : 339 - 343
12345